Avastin is a targeted therapy that may be used off-label in combination with Taxol to treat certain people with metastatic HER2-negative breast.
Metastatic breast cancer (MBC) is a major cause of death among women worldwide. Progress has been made in treating MBC with the advent of anti- estrogen.
The specific indication that was withdrawn was for the use of bevacizumab in metastatic breast cancer, with paclitaxel for the treatment of.
WebMD reports on the FDA's decision to remove Avastin's indication as a breast cancer treatment.